Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease, Journal of Clinical Investigation, vol.115, issue.7, pp.1688-1698, 2005. ,
DOI : 10.1172/JCI25669
Respiratory Syncytial Virus and Parainfluenza Virus, New England Journal of Medicine, vol.344, issue.25, pp.1917-1928, 2001. ,
DOI : 10.1056/NEJM200106213442507
Progress in the development of human parainfluenza virus vaccines, Expert Review of Respiratory Medicine, vol.5, issue.4, pp.515-526, 2011. ,
DOI : 10.1586/ers.11.32
Human parainfluenza virus type 3 (HPIV 3) viral community-acquired pneumonia (CAP) mimicking swine influenza (H1N1) during the swine flu pandemic, Heart & Lung: The Journal of Acute and Critical Care, vol.40, issue.1, pp.76-80, 2011. ,
DOI : 10.1016/j.hrtlng.2010.05.060
Viral Infection in Adults Hospitalized With Community-Acquired Pneumonia, CHEST Journal, vol.134, issue.6, pp.1141-1148, 2008. ,
DOI : 10.1378/chest.08-0888
Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit, J. Clin. Microbiol, vol.36, pp.2289-2293, 1998. ,
Receptor Specificities of Human Respiroviruses, Journal of Virology, vol.75, issue.10, pp.4604-4613, 2001. ,
DOI : 10.1128/JVI.75.10.4604-4613.2001
Infection of Ciliated Cells by Human Parainfluenza Virus Type 3 in an In Vitro Model of Human Airway Epithelium, Journal of Virology, vol.79, issue.2, pp.1113-1124, 2005. ,
DOI : 10.1128/JVI.79.2.1113-1124.2005
Hemagglutinin???Neuraminidase of Human Parainfluenza 3: Role of the Neuraminidase in the Viral Life Cycle, Virology, vol.214, issue.1, pp.294-300, 1995. ,
DOI : 10.1006/viro.1995.9925
Mechanism of Fusion Triggering by Human Parainfluenza Virus Type III: COMMUNICATION BETWEEN VIRAL GLYCOPROTEINS DURING ENTRY, Journal of Biological Chemistry, vol.287, issue.1, pp.778-793, 2012. ,
DOI : 10.1074/jbc.M111.298059
Human Parainfluenza Virus Infection of the Airway Epithelium: Viral Hemagglutinin-Neuraminidase Regulates Fusion Protein Activation and Modulates Infectivity, Journal of Virology, vol.83, issue.13, pp.6900-6908, 2009. ,
DOI : 10.1128/JVI.00475-09
Regulation of Paramyxovirus Fusion Activation: the Hemagglutinin-Neuraminidase Protein Stabilizes the Fusion Protein in a Pretriggered State, Journal of Virology, vol.86, issue.23, pp.12838-12848, 2012. ,
DOI : 10.1128/JVI.01965-12
Influence of the Human Parainfluenza Virus 3 Attachment Protein's Neuraminidase Activity on Its Capacity To Activate the Fusion Protein, Journal of Virology, vol.79, issue.4, pp.2383-2392, 2005. ,
DOI : 10.1128/JVI.79.4.2383-2392.2005
Triggering of Human Parainfluenza Virus 3 Fusion Protein (F) by the Hemagglutinin-Neuraminidase (HN) Protein: an HN Mutation Diminishes the Rate of F Activation and Fusion, Journal of Virology, vol.77, issue.6, pp.3647-3654, 2003. ,
DOI : 10.1128/JVI.77.6.3647-3654.2003
Paramyxovirus Receptor-Binding Molecules: Engagement of One Site on the Hemagglutinin-Neuraminidase Protein Modulates Activity at the Second Site, Journal of Virology, vol.80, issue.3, pp.1204-1213, 2006. ,
DOI : 10.1128/JVI.80.3.1204-1213.2006
Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity, Bioorganic & Medicinal Chemistry Letters, vol.17, issue.6, pp.1655-1658, 2007. ,
DOI : 10.1016/j.bmcl.2006.12.105
Effect of Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 on Growth and Pathogenicity of Sendai/Human Parainfluenza Type 3 Chimera Virus in Mice, Antimicrobial Agents and Chemotherapy, vol.53, issue.9, pp.3942-3951, 2009. ,
DOI : 10.1128/AAC.00220-09
Inhibition of the neuraminidase of paramyxoviruses by halide ions: A possible means of modulating the two activities of the HN protein, Virology, vol.112, issue.1, pp.296-305, 1981. ,
DOI : 10.1016/0042-6822(81)90635-8
Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin???neuraminidase inhibitors, Nature Communications, vol.50, p.5268, 2014. ,
DOI : 10.1038/ncomms6268
Sialidases: structures, biological significance and therapeutic potential, Current Opinion in Structural Biology, vol.6, issue.6, pp.830-837, 1996. ,
DOI : 10.1016/S0959-440X(96)80014-5
The Anti-Influenza Virus Agent 4-GU-DANA (Zanamivir) Inhibits Cell Fusion Mediated by Human Parainfluenza Virus and Influenza Virus HA, Journal of Virology, vol.74, issue.23, pp.11108-11114, 2000. ,
DOI : 10.1128/JVI.74.23.11108-11114.2000
Human Parainfluenza Virus Type 3 HN-Receptor Interaction: Effect of 4-Guanidino-Neu5Ac2en on a Neuraminidase-Deficient Variant, Journal of Virology, vol.75, issue.16, pp.7481-7488, 2001. ,
DOI : 10.1128/JVI.75.16.7481-7488.2001
Efficacy of the novel parainfluenza virus haemagglutinin-neuraminidase inhibitor BCX 2798 in mice ??? further evaluation, Antiviral Therapy, vol.14, issue.7, pp.891-898, 2009. ,
DOI : 10.3851/IMP1420
Efficacy of Novel Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 against Human Parainfluenza Viruses In Vitro and In Vivo, Antimicrobial Agents and Chemotherapy, vol.48, issue.5, pp.1495-1502, 2004. ,
DOI : 10.1128/AAC.48.5.1495-1502.2004
Exposing the Flexibility of Human Parainfluenza Virus Hemagglutinin-neuraminidase, Journal of the American Chemical Society, vol.134, issue.44, pp.18447-18452, 2012. ,
DOI : 10.1021/ja3084658
The Catalytic Mechanism of Human Parainfluenza Virus Type???3 Haemagglutinin-Neuraminidase Revealed, Angewandte Chemie International Edition, vol.53, issue.10, pp.2936-2940, 2015. ,
DOI : 10.1002/anie.201412243
The Human African Trypanosomiasis Control and Surveillance Programme of the World Health Organization 2000???2009: The Way Forward, PLoS Neglected Tropical Diseases, vol.13, issue.2, p.1007, 2000. ,
DOI : 10.1371/journal.pntd.0001007.g004
A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays, Journal of Biomolecular Screening, vol.4, issue.2, pp.67-73, 1999. ,
DOI : 10.1177/108705719900400206
Specificity studies on the oligosaccharide neuraminidase of human fibroblasts, Biochemical Journal, vol.218, issue.2, pp.625-628, 1984. ,
DOI : 10.1042/bj2180625
Lysosomal and Plasma Membrane Ganglioside GM3 Sialidases of Cultured Human Fibroblasts. Differentiation by Detergents and Inhibitors, Biological Chemistry Hoppe-Seyler, vol.372, issue.1, pp.443-450, 1991. ,
DOI : 10.1515/bchm3.1991.372.1.443
Substrate Specificity and Inhibitor Studies of a Membrane-Bound Ganglioside Sialidase Isolated from Human Brain Tissue, Biological Chemistry, vol.383, issue.11, pp.1735-1742, 2002. ,
DOI : 10.1515/BC.2002.194
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors, Advances in Enzyme Regulation, vol.22, pp.27-55, 1984. ,
DOI : 10.1016/0065-2571(84)90007-4
Analysis of combined drug effects: a new look at a very old problem, Trends in Pharmacological Sciences, vol.4, pp.450-454, 1983. ,
DOI : 10.1016/0165-6147(83)90490-X
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies, Pharmacological Reviews, vol.58, issue.3, pp.621-681, 2006. ,
DOI : 10.1124/pr.58.3.10
24138 | DOI: 10.1038/srep24138 37 Avian influenza H5-containing virus-like particles (VLPs): host-cell receptor specificity by STD NMR spectroscopy, Scientific RepoRts | Angew. Chem. Int. Ed. Engl, vol.6, issue.47, pp.1910-1912, 2008. ,
Structure of the Haemagglutinin-neuraminidase from Human Parainfluenza Virus Type III, Journal of Molecular Biology, vol.335, issue.5, pp.1343-1357, 2004. ,
DOI : 10.1016/j.jmb.2003.11.032
Spring-Loaded Model Revisited: Paramyxovirus Fusion Requires Engagement of a Receptor Binding Protein beyond Initial Triggering of the Fusion Protein, Journal of Virology, vol.85, issue.24, pp.12867-12880, 2011. ,
DOI : 10.1128/JVI.05873-11
Inhibition of Parainfluenza Virus Type 3 and Newcastle Disease Virus Hemagglutinin-Neuraminidase Receptor Binding: Effect of Receptor Avidity and Steric Hindrance at the Inhibitor Binding Sites, Journal of Virology, vol.78, issue.24, pp.13911-13919, 2004. ,
DOI : 10.1128/JVI.78.24.13911-13919.2004
Ligand Screening by Saturation-Transfer Difference (STD) NMR Spectroscopy, Current Analytical Chemistry, vol.1, issue.3, pp.307-320, 2005. ,
DOI : 10.2174/157341105774573956
The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection???suramin inhibits EV71 infection in vitro and in vivo, Emerging Microbes & Infections, vol.52, issue.9, p.62, 2014. ,
DOI : 10.1128/AAC.01433-10
URL : https://hal.archives-ouvertes.fr/pasteur-01179295
The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor, Carbohydrate Research, vol.259, issue.2, pp.301-305, 1994. ,
DOI : 10.1016/0008-6215(94)84065-2
Isolation of a biologically active soluble form of the hemagglutininneuraminidase protein of Sendai virus, J. Virol, vol.62, pp.4653-4660, 1988. ,
Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-??-d-N-acetylneuraminate) substrate, Analytical Biochemistry, vol.94, issue.2, pp.287-296, 1979. ,
DOI : 10.1016/0003-2697(79)90362-2
Inhibition of human parainfluenza virus type 1 sialidase by analogs of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid, Glycoconjugate Journal, vol.18, issue.4, pp.331-337, 2001. ,
DOI : 10.1023/A:1013617232576
Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C-4 position, Glycoconjugate Journal, vol.25, issue.1, pp.40-44, 1993. ,
DOI : 10.1007/BF00731185
Characteristic of neuraminidase inhibitory xanthones from Cudrania tricuspidata, Bioorganic & Medicinal Chemistry, vol.17, issue.7, pp.2744-2750, 2009. ,
DOI : 10.1016/j.bmc.2009.02.042
Prenylated pterocarpans as bacterial neuraminidase inhibitors, Bioorganic & Medicinal Chemistry, vol.18, issue.9, pp.3335-3344, 2010. ,
DOI : 10.1016/j.bmc.2010.03.005
N-Linked Glycan at Residue 523 of Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Masks a Second Receptor-Binding Site, Journal of Virology, vol.84, issue.6, pp.3094-3100, 2010. ,
DOI : 10.1128/JVI.02331-09
Fiji: an open-source platform for biological-image analysis, Nature Methods, vol.27, issue.7, pp.676-682, 2012. ,
DOI : 10.1038/nmeth.2019
Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands, Journal of Theoretical Biology, vol.59, issue.2, pp.253-276, 1976. ,
DOI : 10.1016/0022-5193(76)90169-7
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, Journal of Computational Chemistry, vol.17, pp.455-461, 2010. ,
DOI : 10.1002/jcc.21334
: a tool for high-throughput crystallography of protein???ligand complexes, Acta Crystallographica Section D Biological Crystallography, vol.60, issue.8, pp.1355-1363, 2004. ,
DOI : 10.1107/S0907444904011679